Rosenblatt cuts Zscaler stock price target on FY27 growth concerns By Investing.com

Rosenblatt cut Zscaler’s price target to $200 from $223 but kept a Buy rating, as the company posted 30% growth in remaining performance obligations to $6.5 billion and 24% revenue growth over the last twelve months. Key operating metrics remain strong, including 19% growth in customers with over $100,000 in ARR and AI Protect bookings surpassing $100 million, but analysts remain cautious on fiscal 2027 ARR durability. The stock has fallen 26.74% over the past six months, and recent analyst target cuts point to a still mixed sentiment backdrop.

Analysis

ZS remains a quality compounder, but the market is now punishing any ambiguity around the slope of future net new ARR rather than the absolute growth rate. That shifts the stock from a “beats-and-raises” multiple story to a credibility story: if management can’t re-accelerate long-duration bookings conversion into fiscal 2027, the valuation will keep compressing even if revenue stays healthy. The most important second-order effect is that larger security platforms with broader bundles can use price and packaging to slow stand-alone best-of-breed vendors without needing to win outright share.

The current setup is still constructive operationally because non-seat-based modules and AI/data products are extending contract duration and increasing wallet share, but that cuts both ways. When growth is increasingly driven by attach and expansion rather than first-order customer adds, the market starts to view each quarter through a “sustainability of mix” lens, so any deceleration in one product line gets extrapolated aggressively. That helps explain why the stock can stay range-bound even with solid gross margin and backlog metrics: the sell side is effectively discounting a future reset in growth quality, not current demand.

The contrarian angle is that the selloff may already reflect a worst-case normalization of growth far below what the installed base and large-customer expansion suggest is realistic. If fiscal 2027 guidance is merely conservative rather than decelerating, ZS can rerate quickly because short interest and sentiment are still vulnerable to a single confidence-restoring guidepost. The key catalyst window is the next 1-2 earnings prints: the stock likely trades on management’s ability to show durable conversion from pipeline to ARR, not on macro or sector sympathy.

Key Decisions for Investors

• Hold a tactical long ZS into the next earnings cycle only if the stock remains range-bound; target a 10-15% upside re-rating on any evidence of fiscal 2027 ARR durability, with a tight 7-8% stop if guidance de-risks less than expected.
• Buy ZS Jan-2026 calls and finance partly by selling upside calls against a higher strike to express a convex recovery view; this is attractive if you think confidence can return in 1-2 quarters but downside is capped by existing valuation compression.
• Pair trade: long ZS / short a broader security basket that has more exposed near-term guidance risk, to isolate idiosyncratic upside from a confidence reset while reducing beta to the software multiple de-rating.
• If already long, reduce position size into strength unless management explicitly lifts fiscal 2027 core ARR visibility; the risk/reward shifts unfavorably if the market keeps re-pricing ZS as a mature platform rather than a growth compounder.